Sunnyvale, Calif.-based surgical robotics maker Intuitive Surgical (NSDQ:ISRG) lost a little Wall Street love today after the company reported 4th quarter and fiscal 2013 financial figures.
MassDevice Earnings Roundup
Baxter beats The Street with Q4 numbers, but Gambro buy pushes profits down
Hill-Rom lays of 350 to save $30M amid rough outlook
Hill-Rom Holdings (NYSE:HRC) announced today that it will cut about 350 employees in efforts to save about $30 million annually as the device maker looks forward to a potentially tough year.
Stryker plans full knee replacement trial for Mako robotic surgery platform this year
Abbott’s Q4, 2013 earnings meet The Street
St. Jude Medical beats The Street with Q4, 2013 numbers
St. Jude Medical (NYSE:STJ) topped expectations on Wall Street with its 4th-quarter and 2013 results, prompting early-bird investors to send share prices up today in pre-market trading.
Investors balk at J&J’s 2014 guidance despite Q4, 2013 growth
Johnson & Johnson (NYSE:JNJ) shares are down this morning after the healthcare conglomerate said it expects its 2014 earnings to be a penny below expectations and posted strong sales and profit growth for the 4th quarter and 2013.
GE Healthcare grows profits among declining sales in Q4 and 2013
NuVasive soars on estimates for Q4 and 2014
California medical device maker NuVasive Inc. (NSDQ:NUVA) is flying high today after raising its revenue projections for 2013 amid higher-than-expected 4th quarter sales.
Globus Medical gains a bit on strong Q4 prelims
Globus Medical (NYSE:GMED) blew the doors off of the sluggish growth rate for the spinal implant market during the 4th quarter, topping Wall Street’s expectations and sending share prices up today.
HeartWare slides on missed Q4 prelims
HeartWare International (NSDQ:HTWR) said it expects to report 4th-quarter revenues of roughly $53 million, missing the consensus view on Wall Street of $58 million and sending its share price down sharply in pre-market trading.